Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn D Scott

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|November 3, 2015
Soluble M6P/IGFIIR in the circulationCarolyn D Scott, Wieland Kiess
International Journal of Cancer|May 21, 2013
Silencing the mannose 6-phosphate/IGF-II receptor differentially affects tumorigenic properties of normal breast epithelial cellsNicole J Caixeiro, Janet L Martin, Carolyn D Scott
Pediatric Research|January 5, 2002
Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis?Stefano Cianfarani, Caterina Geremia, Carolyn D Scott, et al.
International Journal of Cancer|October 2, 2003
Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivoJason S Lee, Jocelyn Weiss, Janet L Martin, et al.
Endocrinology|October 26, 2002
Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivoDavid B O'Gorman, Jocelyn Weiss, Anusha Hettiaratchi, et al.
Molecular Cancer Therapeutics|December 17, 2013
Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockadeJanet L Martin, Hasanthi C de Silva, Mike Z Lin, et al.
Experimental Cell Research|November 13, 2018
Contrasting effects of IGF binding protein-3 expression in mammary tumor cells and the tumor microenvironmentTiffany Scully, Carolyn D Scott, Sue M Firth, et al.
Endocrine-Related Cancer|December 9, 2017
Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulationTiffany Scully, Carolyn D Scott, Sue M Firth, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 21, 2005
Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood heightClive J Petry, Ken K Ong, Dianne L Wingate, et al.
Oncotarget|July 25, 2016
Insulin-like growth factor binding protein-3 links obesity and breast cancer progressionTiffany Scully, Sue M Firth, Carolyn D Scott, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Endocrinology & Metabolism|November 3, 2015
Soluble M6P/IGFIIR in the circulationCarolyn D Scott, Wieland Kiess
International Journal of Cancer|May 21, 2013
Silencing the mannose 6-phosphate/IGF-II receptor differentially affects tumorigenic properties of normal breast epithelial cellsNicole J Caixeiro, Janet L Martin, Carolyn D Scott
Pediatric Research|January 5, 2002
Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis?Stefano Cianfarani, Caterina Geremia, Carolyn D Scott, et al.
International Journal of Cancer|October 2, 2003
Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivoJason S Lee, Jocelyn Weiss, Janet L Martin, et al.
Endocrinology|October 26, 2002
Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivoDavid B O'Gorman, Jocelyn Weiss, Anusha Hettiaratchi, et al.
Molecular Cancer Therapeutics|December 17, 2013
Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockadeJanet L Martin, Hasanthi C de Silva, Mike Z Lin, et al.
Experimental Cell Research|November 13, 2018
Contrasting effects of IGF binding protein-3 expression in mammary tumor cells and the tumor microenvironmentTiffany Scully, Carolyn D Scott, Sue M Firth, et al.
Endocrine-Related Cancer|December 9, 2017
Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulationTiffany Scully, Carolyn D Scott, Sue M Firth, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 21, 2005
Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood heightClive J Petry, Ken K Ong, Dianne L Wingate, et al.
Oncotarget|July 25, 2016
Insulin-like growth factor binding protein-3 links obesity and breast cancer progressionTiffany Scully, Sue M Firth, Carolyn D Scott, et al.
Pageof 1